Analyses of Potential Predictive Markers and Survival Data for a Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analyses of Potential Predictive Markers and Survival Data for a Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma

Published:2013-09-27 Issue:9 Volume:8 Page:e76386
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dornbusch Juana,Zacharis Aristeidis,Meinhardt Matthias,Erdmann Kati,Wolff Ingmar,Froehner Michael,Wirth Manfred P.,Zastrow Stefan,Fuessel Susanne

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference64 articles.

1. Immunotherapy for renal cell carcinoma;I Bleumer;Eur Urol,2003

2. Use of interleukin-2 in advanced renal carcinoma: meta-analysis and review of the literature;M Malaguarnera;Eur J Clin Pharmacol,2001

3. Sunitinib in patients with metastatic renal cell carcinoma;RJ Motzer;Jama,2006

4. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;RJ Motzer;J Clin Oncol,2009

5. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma;RJ Motzer;J Clin Oncol,2006

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial;Nature Communications;2024-01-23

2. A systematic review verified by bioinformatic analysis based on TCGA reveals week prognosis power of CAIX in renal cancer;PLOS ONE;2022-12-21

3. Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies;Cancers;2022-12-14

4. Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib;Bosnian Journal of Basic Medical Sciences;2022-06-08

5. Surgically induced ischemia has no impact on protein expression levels of HIF‐1α and related biomarkers in renal cell carcinoma;APMIS;2021-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3